Corden Pharma Chenove, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BISOPROLOL FUMARATE, with a corresponding US DMF Number 13910.
Remarkably, this DMF maintains an Active status since its submission on December 22, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 08, 2018, and payment made on October 10, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II